Abivax stock skyrocketed in July after the company announced overwhelmingly positive topline results from its Phase 3 ...
An end-of-the-year slowdown has not been witnessed by the biopharma industry yet, and certainly not in the biotech deals ...
Zacks Investment Research on MSN
LLY trading above 50 & 200-day SMAs for 2 months: How to play the stock
Eli Lilly and Company’s LLY stock has been consistently trading above its 50-day and 200-day simple moving averages (SMAs) ...
Despite a challenging CASGEVY launch, high cash burn, and an almost 10% YTD share count growth, CRISPR’s pipeline breadth and ...
Explore Intellia Therapeutics, Inc.'s outlook after Phase 3 trial concerns. See how FDA decisions may impact CRISPR therapy ...
ToolGen Inc. (KOSDAQ: 199800), a leading genome editing company based in Korea, announced today that it has entered into a strategic cross-license agreement with GenEditBio Limited ("GenEditBio"), a ...
Verve has hired Amanda Lie as an agent on their talent team, Variety has learned exclusively. Lie joins Verve from M88, where she worked as a talent manager since December 2024. Prior to that, she was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback